Financhill
Sell
31

MNPR Quote, Financials, Valuation and Earnings

Last price:
$30.03
Seasonality move :
-28.14%
Day range:
$30.20 - $34.11
52-week range:
$1.72 - $54.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
32.97x
Volume:
17.8K
Avg. volume:
54.7K
1-year change:
648.18%
Market cap:
$163.1M
Revenue:
--
EPS (TTM):
-$1.99

Earnings Data

Next earnings date for MNPR
Mar 28
2025
Most recent earnings per share
-$0.37
Beat by $0.80
(Nov 8/2024)
Consensus Estimate
-$1.17
(Nov 8/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MNPR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 -- -- -- -$0.53 --
03/28/2025 Q4 -- -- -- -$0.42 --
11/08/2024 Q3 -- -- -$0.37 -$1.17 $0.80
08/09/2024 Q2 -- -- -$0.50 -$0.47 -$0.03
05/09/2024 Q1 -- -- -$0.50 -$0.85 $0.35
03/28/2024 Q4 -- -- -$0.62 -$0.85 $0.23
11/09/2023 Q3 -- -- -$0.69 -$0.95 $0.26
08/11/2023 Q2 -- -- -$0.80 -$0.95 $0.15
05/11/2023 Q1 -- -- -$0.95 -$1.08 $0.13
03/23/2023 Q4 -- -- -$1.15 -$1.03 -$0.13
11/10/2022 Q3 -- -- -$0.95 -$1.08 $0.13
08/11/2022 Q2 -- -- -$1.10 -- --
05/12/2022 Q1 -- -- -$0.95 -- --
03/24/2022 Q4 -- -- -$1.05 -- --
11/12/2021 Q3 -- -- -$1.00 -- --
08/12/2021 Q2 -- -- -$0.85 -- --
05/13/2021 Q1 -- -- -$0.80 -- --
03/25/2021 Q4 -- -- -$0.95 -- --
11/12/2020 Q3 -- -- -$0.75 -- --
08/06/2020 Q2 -- -- -$0.70 -- --
05/07/2020 Q1 -- -- -$0.50 -- --
03/27/2020 Q4 -- -- -$0.57 -- --
09/30/2019 Q3 -- -- -$0.35 -- --
06/30/2019 Q2 -- -- -$0.43 -- --
03/31/2019 Q1 -- -- -$0.66 -- --
12/31/2018 Q4 -- -- -$0.43 -- --
09/30/2018 Q3 -- -- -$0.31 -- --
06/30/2018 Q2 -- -- -$0.36 -- --
03/31/2018 Q1 -- -- -$0.42 -- --
12/31/2017 Q4 -- -- -$0.34 -- --
09/30/2017 Q3 -- -- -$7.14 -- --
06/30/2017 Q2 -- -- -$0.28 -- --
03/31/2017 Q1 -- -- -$0.18 -- --

Monopar Therapeutics Earnings Questions

  • How Much did Monopar Therapeutics Generate in Revenue Last Quarter?

    Monopar Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Monopar Therapeutics Beat Earnings Last Quarter?

    Monopar Therapeutics announced earnings per share of -$0.37 which represents a beat of analyst forecast a -$1.17 per share.

  • Is Monopar Therapeutics Profitable?

    Monopar Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Monopar Therapeutics EPS Next Year?

    Monopar Therapeutics's earnings are forecast to decrease from -$3.05 per share to -$1.77 per share next year representing a decrease of -41.86%.

  • When is Monopar Therapeutics's Earnings Date?

    Monopar Therapeutics's next earnings date is March 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Tesla Stock: The Bear Case
Tesla Stock: The Bear Case

The recent stock market drop has been a punishing time…

Is VUG a Good ETF to Buy?
Is VUG a Good ETF to Buy?

For the last few years, earnings growth from the tech…

Does Intel Stock Have Room to Grow?
Does Intel Stock Have Room to Grow?

Intel Corporation (NASDAQ:INTC)’s recent innovations, Xeon 6 SoC and Xeon®…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Sell
50
TREE alert for Mar 13

LendingTree [TREE] is up 1.53% over the past day.

Buy
57
INOD alert for Mar 13

Innodata [INOD] is down 7.4% over the past day.

Sell
40
VIST alert for Mar 13

Vista Energy SAB de CV [VIST] is up 0.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock